From Our Readers

From Our Readers

Impatient Practicum

In his April 2017 Editor’s Corner, Editor-in-Chief Mikkael Sekeres issued his annual missive to the American Board of Internal Medicine (“Letter from a Cleveland...

Bleeding Risk in a Pregnant Patient with Factor XI Deficiency

Here’s how readers responded to a You Make the Call question about pregnant 38-year-old female patient with factor XI deficiency. Disclaimer: ASH does not recommend...

Prescribing options in the case of anticoagulation failure in deep vein thrombosis

Here’s how readers responded to a You Make the Call question about a patient's prescribing options for failed anticoagulation in a case of deep vein...

Severe macrocytic anemia in a patient with CMML-1

Here's how readers responded to a You Make the Call question about the management of severe macrocytic anemia in a 73-year-old male patient with chronic...

Not-So-NICE One

In December 2016, we published an Online Exclusive item reporting on the United Kingdom’s National Institute for Health and Care Excellence’s (NICE) review of...

Another Clinical Research Secret

In the December 2016 Editor’s Corner (“So You Say You Want to Be a Clinical Researcher?”), Mikkael A. Sekeres, MD, MS, offered advice for...

The Family That Puzzles Together …

In December’s issue, Associate Editor David Steensma, MD, shared his lifelong love of word games, and how he went from fighting over the newspaper...

Marrow-Minded

In November’s Editor’s Corner, David Steensma, MD, recounted the “absurdly exotic experience” of eating bone marrow in a café in Milan after speaking about...

How long should a patient continue anticoagulation and should she continue during pregnancy?

Here's how readers responded to a You Make the Call question about anticoagulation during pregnancy. Disclaimer: ASH does not recommend or endorse any specific tests,...

A Response on Email Etiquette

In October’s Editor’s Corner, Editor-in-Chief Mikkael A. Sekeres, MD, MS, and his colleague at Cleveland Clinic, Jennifer Lonzer, MA, provided “A Primer on Email...
Advertisement

Current Issue

May 2017, Volume 3, Issue 6

This issue discusses the legacy of Agent Orange and hematologic malignancies, a debate over transplant in myelodysplastic syndromes, and more.